1-(Bromomethyl)-2-(trifluoromethyl)benzene structure
|
Common Name | 1-(Bromomethyl)-2-(trifluoromethyl)benzene | ||
---|---|---|---|---|
CAS Number | 395-44-8 | Molecular Weight | 239.032 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 201.9±0.0 °C at 760 mmHg | |
Molecular Formula | C8H6BrF3 | Melting Point | 34-35ºC | |
MSDS | Chinese USA | Flash Point | 83.3±0.0 °C | |
Symbol |
GHS05 |
Signal Word | Danger |
Name | 1-(bromomethyl)-2-(trifluoromethyl)benzene |
---|---|
Synonym | More Synonyms |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 201.9±0.0 °C at 760 mmHg |
Melting Point | 34-35ºC |
Molecular Formula | C8H6BrF3 |
Molecular Weight | 239.032 |
Flash Point | 83.3±0.0 °C |
Exact Mass | 237.960495 |
LogP | 3.49 |
Vapour Pressure | 0.4±0.3 mmHg at 25°C |
Index of Refraction | 1.488 |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | C:Corrosive; |
Risk Phrases | R34 |
Safety Phrases | S25-S36/37/39-S45 |
RIDADR | UN 3265 |
Packaging Group | III |
Hazard Class | 8.0 |
HS Code | 2903999090 |
~% 1-(Bromomethyl)... CAS#:395-44-8 |
Literature: Filler,R.; Novar,H. Journal of Organic Chemistry, 1960 , vol. 25, p. 733 - 736 |
~% 1-(Bromomethyl)... CAS#:395-44-8 |
Literature: Short,J.H.; Biermacher,U. Journal of Pharmaceutical Sciences, 1962 , vol. 51, p. 881 - 884 |
~% 1-(Bromomethyl)... CAS#:395-44-8 |
Literature: Filler,R.; Novar,H. Journal of Organic Chemistry, 1960 , vol. 25, p. 733 - 736 |
~% 1-(Bromomethyl)... CAS#:395-44-8 |
Literature: van der Stelt,C. et al. Arzneimittel Forschung, 1965 , vol. 15, p. 1251 - 1253 |
Precursor 4 | |
---|---|
DownStream 6 | |
HS Code | 2903999090 |
---|---|
Summary | 2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.
J. Comb. Chem. 11(1) , 34-43, (2009) For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib... |
|
Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.
J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... |
2-(Trifluoromethyl)benzylbromide |
1-(Bromomethyl)-2-(trifluoromethyl)benzene |
2-Trifluoromethylbenzyl bromide |
2-(Bromomethyl)benzotrifluoride |
1-bromomethyl-2-trifluoromethylbenzene |
2-(Trifluoromethyl)benzyl Bromide |
FXFFR B1E |
2-trifluoromethylphenylmethyl bromide |
MFCD00013558 |
Benzene, 1-(bromomethyl)-2-(trifluoromethyl)- |
EINECS 206-901-7 |
alpha‘-Bromo-alpha,alpha,alpha-trifluoro-o-xylene |
α-Bromo-α',α',α'-trifluoro-o-xylene |